Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3
Rachaneekorn Tammachote(Chulalongkorn University), Peter C. Harris(Mayo Clinic), Peter G. Czarnecki(Beth Israel Deaconess Medical Center), Amanda C. Leightner(University of Minnesota), Vicente E. Torres(Mayo Clinic in Arizona), Christopher J. Ward(University of Kansas Medical Center), Caroline A. Miller(Hadassah Medical Center), Cynthia J. Hommerding(Mayo Clinic), Jeffrey L. Salisbury(Mayo Clinic), Vincent H. Gattone(Indiana University School of Medicine), Rachel M. Sinders(Indiana University School of Medicine)
Cited by 125
Related Papers
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
|Kidney International|2015|602
Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease
|New England Journal of Medicine|2014|524
Mutations in GANAB , Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease
|The American Journal of Human Genetics|2016|463
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca <sup>2+</sup> -permeable nonselective cation channel
|Proceedings of the National Academy of Sciences|2000|447
Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity
|Journal of Clinical Investigation|2012|444